2020年欧洲心脏病学会使用高灵敏度心肌肌钙蛋白I对非st段抬高急性冠状动脉综合征的0小时/1小时算法的性能评估和基于1年真实世界数据的死亡率评估

IF 3.9 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Changhee Ha, Yeon Jae Lee, Jong Do Seo, Hanah Kim, Hee-Won Moon, Mina Hur, Young Hwan Lee, Sang O Park, Kyeong Ryong Lee, Hyun-Joong Kim, Yeo-Min Yun
{"title":"2020年欧洲心脏病学会使用高灵敏度心肌肌钙蛋白I对非st段抬高急性冠状动脉综合征的0小时/1小时算法的性能评估和基于1年真实世界数据的死亡率评估","authors":"Changhee Ha, Yeon Jae Lee, Jong Do Seo, Hanah Kim, Hee-Won Moon, Mina Hur, Young Hwan Lee, Sang O Park, Kyeong Ryong Lee, Hyun-Joong Kim, Yeo-Min Yun","doi":"10.3343/alm.2025.0017","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The 2020 European Society of Cardiology (ESC) 0-hr/1-hr algorithm using high-sensitivity cardiac troponin I (hs-cTnI) for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) aims at early diagnosis and shorter emergency department (ED) stays. While this algorithm has been well-established in controlled studies, real-world implementation remains challenging. We evaluated the algorithm's clinical performance and risk stratification capability in patients with chest pain or discomfort.</p><p><strong>Methods: </strong>We measured hs-cTnI in 4,678 patients suspected of NSTE-ACS between August 2022 and July 2023, using an Atellica IM Analyzer (Siemens Healthineers, Erlangen, Germany). We categorized patients into rule-in, observe, or rule-out groups according to the algorithm and assessed its diagnostic performance for NSTE-ACS. The final diagnosis of NSTE-ACS was adjudicated by two independent physicians. Additionally, we evaluated 30-day all-cause mortality, hazard risk, and ED length of stay across the three groups.</p><p><strong>Results: </strong>The algorithm categorized 3,408 (72.9%), 573 (12.2%), and 697 (14.9%) patients into the rule-out, observe, and rule-in groups, respectively. Among 90 patients diagnosed as having NSTE-ACS, none were falsely categorized into the rule-out group. Survival analysis revealed significant differences (<i>P</i> <0.001), with Cox hazard ratios of 2.38 (95% confidence interval: 1.20-4.71) and 6.39 (3.45-11.86) in the observe and rule-in groups, respectively. ED stays shortened in the order of rule-out, observe, and rule-in groups (<i>P</i> <0.001).</p><p><strong>Conclusions: </strong>The 2020 ESC 0-hr/1-hr algorithm demonstrates excellent diagnostic accuracy without false rule-outs and effective risk stratification, and contributes to efficient ED throughput, supporting its clinical utility in real-world emergency settings.</p>","PeriodicalId":8421,"journal":{"name":"Annals of Laboratory Medicine","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Performance Evaluation of the 2020 European Society of Cardiology 0-hour/1-hour Algorithm Using High-sensitivity Cardiac Troponin I for Non-ST-segment Elevation Acute Coronary Syndrome and Mortality Assessment Based on 1-year Real-world Data\",\"authors\":\"Changhee Ha, Yeon Jae Lee, Jong Do Seo, Hanah Kim, Hee-Won Moon, Mina Hur, Young Hwan Lee, Sang O Park, Kyeong Ryong Lee, Hyun-Joong Kim, Yeo-Min Yun\",\"doi\":\"10.3343/alm.2025.0017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The 2020 European Society of Cardiology (ESC) 0-hr/1-hr algorithm using high-sensitivity cardiac troponin I (hs-cTnI) for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) aims at early diagnosis and shorter emergency department (ED) stays. While this algorithm has been well-established in controlled studies, real-world implementation remains challenging. We evaluated the algorithm's clinical performance and risk stratification capability in patients with chest pain or discomfort.</p><p><strong>Methods: </strong>We measured hs-cTnI in 4,678 patients suspected of NSTE-ACS between August 2022 and July 2023, using an Atellica IM Analyzer (Siemens Healthineers, Erlangen, Germany). We categorized patients into rule-in, observe, or rule-out groups according to the algorithm and assessed its diagnostic performance for NSTE-ACS. The final diagnosis of NSTE-ACS was adjudicated by two independent physicians. Additionally, we evaluated 30-day all-cause mortality, hazard risk, and ED length of stay across the three groups.</p><p><strong>Results: </strong>The algorithm categorized 3,408 (72.9%), 573 (12.2%), and 697 (14.9%) patients into the rule-out, observe, and rule-in groups, respectively. Among 90 patients diagnosed as having NSTE-ACS, none were falsely categorized into the rule-out group. Survival analysis revealed significant differences (<i>P</i> <0.001), with Cox hazard ratios of 2.38 (95% confidence interval: 1.20-4.71) and 6.39 (3.45-11.86) in the observe and rule-in groups, respectively. ED stays shortened in the order of rule-out, observe, and rule-in groups (<i>P</i> <0.001).</p><p><strong>Conclusions: </strong>The 2020 ESC 0-hr/1-hr algorithm demonstrates excellent diagnostic accuracy without false rule-outs and effective risk stratification, and contributes to efficient ED throughput, supporting its clinical utility in real-world emergency settings.</p>\",\"PeriodicalId\":8421,\"journal\":{\"name\":\"Annals of Laboratory Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Laboratory Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3343/alm.2025.0017\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Laboratory Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3343/alm.2025.0017","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:2020年欧洲心脏病学会(ESC)使用高灵敏度心肌肌钙蛋白I (hs-cTnI)诊断非st段抬高急性冠状动脉综合征(NSTE-ACS)的0小时/1小时算法旨在早期诊断和缩短急诊科(ED)住院时间。虽然该算法已经在对照研究中得到了完善,但在现实世界中的实施仍然具有挑战性。我们评估了该算法在胸痛或不适患者中的临床表现和风险分层能力。方法:在2022年8月至2023年7月期间,我们使用Atellica IM分析仪(Siemens Healthineers, Erlangen, Germany)测量了4678例疑似NSTE-ACS患者的hs-cTnI。我们根据算法将患者分为正常入组、观察组和排除组,并评估其对NSTE-ACS的诊断性能。NSTE-ACS的最终诊断是由两位独立的医生裁决的。此外,我们评估了三组患者的30天全因死亡率、危险风险和ED住院时间。结果:该算法将3408例(72.9%)、573例(12.2%)和697例(14.9%)患者分为排除组、观察组和纳入组。在90名被诊断为NSTE-ACS的患者中,没有人被错误地归类为排除组。结论:2020年ESC 0-hr/1-hr算法具有出色的诊断准确性,无假排除和有效的风险分层,有助于提高ED吞吐量,支持其在现实世界急诊环境中的临床应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Performance Evaluation of the 2020 European Society of Cardiology 0-hour/1-hour Algorithm Using High-sensitivity Cardiac Troponin I for Non-ST-segment Elevation Acute Coronary Syndrome and Mortality Assessment Based on 1-year Real-world Data

Background: The 2020 European Society of Cardiology (ESC) 0-hr/1-hr algorithm using high-sensitivity cardiac troponin I (hs-cTnI) for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) aims at early diagnosis and shorter emergency department (ED) stays. While this algorithm has been well-established in controlled studies, real-world implementation remains challenging. We evaluated the algorithm's clinical performance and risk stratification capability in patients with chest pain or discomfort.

Methods: We measured hs-cTnI in 4,678 patients suspected of NSTE-ACS between August 2022 and July 2023, using an Atellica IM Analyzer (Siemens Healthineers, Erlangen, Germany). We categorized patients into rule-in, observe, or rule-out groups according to the algorithm and assessed its diagnostic performance for NSTE-ACS. The final diagnosis of NSTE-ACS was adjudicated by two independent physicians. Additionally, we evaluated 30-day all-cause mortality, hazard risk, and ED length of stay across the three groups.

Results: The algorithm categorized 3,408 (72.9%), 573 (12.2%), and 697 (14.9%) patients into the rule-out, observe, and rule-in groups, respectively. Among 90 patients diagnosed as having NSTE-ACS, none were falsely categorized into the rule-out group. Survival analysis revealed significant differences (P <0.001), with Cox hazard ratios of 2.38 (95% confidence interval: 1.20-4.71) and 6.39 (3.45-11.86) in the observe and rule-in groups, respectively. ED stays shortened in the order of rule-out, observe, and rule-in groups (P <0.001).

Conclusions: The 2020 ESC 0-hr/1-hr algorithm demonstrates excellent diagnostic accuracy without false rule-outs and effective risk stratification, and contributes to efficient ED throughput, supporting its clinical utility in real-world emergency settings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of Laboratory Medicine
Annals of Laboratory Medicine MEDICAL LABORATORY TECHNOLOGY-
CiteScore
8.30
自引率
12.20%
发文量
100
审稿时长
6-12 weeks
期刊介绍: Annals of Laboratory Medicine is the official journal of Korean Society for Laboratory Medicine. The journal title has been recently changed from the Korean Journal of Laboratory Medicine (ISSN, 1598-6535) from the January issue of 2012. The JCR 2017 Impact factor of Ann Lab Med was 1.916.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信